Literature DB >> 17882124

State-specific influenza vaccination coverage among adults aged > or =18 years--United States, 2003-04 and 2005-06 influenza seasons.

.   

Abstract

Influenza epidemics occur seasonally and result in substantial morbidity and mortality among adults in the United States. Adult groups included in the 2007 Advisory Committee on Immunization Practices (ACIP) recommendation for annual influenza vaccination are persons aged 18-49 years with high-risk conditions (i.e., conditions associated with an increased risk for complications from influenza), persons aged > or =50 years, health-care personnel, and others who are household contacts or caregivers of persons at high risk (e.g., persons with high-risk conditions or children aged < or =59 months). In addition, adults who want to reduce the risk for becoming ill with influenza or of transmitting influenza to others should be vaccinated. Healthy People 2010 (HP2010) objectives include increasing vaccination levels to 90% for adults aged > or =65 years (objective 14-29a) and 60% for persons aged 18-64 years who have one or more high-risk conditions (objective 14-29c). From the 1992-93 through 2003-04 influenza seasons, seasonal influenza vaccination coverage estimates (based on Behavioral Risk Factor Surveillance System [BRFSS] data) among adults aged > or =65 years trended upward, except for three seasons (1997-98, 1999-00, and 2000-01) when no increases occurred (Figure). To evaluate recent state-specific progress toward the HP2010 objectives, CDC compared data from the 2004 and 2006 BRFSS surveys, which reflected vaccinations received during the 2003-04 and 2005-06 influenza seasons; data from the 2004-05 influenza season, which have been published previously, were not included in this comparison because that season was marked by a substantial shortage of influenza vaccine. This report describes the results of the analysis, which indicated that influenza vaccination coverage for the 2005-06 season did not return to levels observed before the vaccine shortage of 2004-05 and remained substantially below HP2010 targets. Comprehensive measures are needed to improve influenza vaccination coverage among adult populations in the United States, including increasing adoption of recommended adult immunization practices by health-care providers, raising public awareness about influenza vaccination, vaccinating throughout the influenza season, and ensuring stable supplies of readily available vaccine.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17882124

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  11 in total

1.  Influenza exerts continued pressure in an era of modern medicine.

Authors:  James W Noah; Diana L Noah; Sadis Matalon
Journal:  Am J Respir Cell Mol Biol       Date:  2009-05-07       Impact factor: 6.914

2.  Increasing inner-city adult influenza vaccination rates: a randomized controlled trial.

Authors:  Sharon G Humiston; Nancy M Bennett; Christine Long; Shirley Eberly; Lourdes Arvelo; Joseph Stankaitis; Peter G Szilagyi
Journal:  Public Health Rep       Date:  2011 Jul-Aug       Impact factor: 2.792

3.  Influenza vaccination coverage among high-risk groups in 11 European countries.

Authors:  Adrian Loerbroks; Christian Stock; Jos A Bosch; David G Litaker; Christian J Apfelbacher
Journal:  Eur J Public Health       Date:  2011-07-12       Impact factor: 3.367

4.  From the patient perspective: the economic value of seasonal and H1N1 influenza vaccination.

Authors:  Bruce Y Lee; Kristina M Bacon; Julie M Donohue; Ann E Wiringa; Rachel R Bailey; Richard K Zimmerman
Journal:  Vaccine       Date:  2011-01-06       Impact factor: 3.641

5.  Predictors of reported influenza vaccination in HIV-infected women in the United States, 2006-2007 and 2007-2008 seasons.

Authors:  Keri N Althoff; Kathryn Anastos; Kenrad E Nelson; David D Celentano; Gerald B Sharp; Ruth M Greenblatt; Audrey L French; Don J Diamond; Susan Holman; Mary Young; Stephen J Gange
Journal:  Prev Med       Date:  2010-03-18       Impact factor: 4.018

6.  Predictors of influenza vaccination in the Cystic Fibrosis Foundation patient registry, 2006 through 2007.

Authors:  Justin R Ortiz; Kathleen M Neuzil; John C Victor; Moira L Aitken; Christopher H Goss
Journal:  Chest       Date:  2010-05-21       Impact factor: 9.410

7.  Alternative vaccination locations: who uses them and can they increase flu vaccination rates?

Authors:  Bruce Y Lee; Ateev Mehrotra; Rachel M Burns; Katherine M Harris
Journal:  Vaccine       Date:  2009-05-09       Impact factor: 3.641

Review 8.  Patient reminder and patient recall systems to improve immunization rates.

Authors:  Julie C Jacobson Vann; Peter Szilagyi
Journal:  Cochrane Database Syst Rev       Date:  2005-07-20

Review 9.  Current evidence on intradermal influenza vaccines administered by Soluvia™ licensed micro injection system.

Authors:  Giancarlo Icardi; Andrea Orsi; Antonella Ceravolo; Filippo Ansaldi
Journal:  Hum Vaccin Immunother       Date:  2012-01-01       Impact factor: 3.452

10.  Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial.

Authors:  Jiri Beran; Arvydas Ambrozaitis; Alvydas Laiskonis; Narseta Mickuviene; Patrick Bacart; Yvan Calozet; Etienne Demanet; Stephane Heijmans; Paul Van Belle; Françoise Weber; Camille Salamand
Journal:  BMC Med       Date:  2009-04-02       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.